Private Advisor Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,623
Closed -$1.73M 2684
2025
Q3
$1.73M Buy
23,623
+184
+0.8% +$12.2K 0.01% 1082
2025
Q2
$1.22M Sell
23,439
-6,061
-21% -$345K 0.01% 1201
2025
Q1
$1.88M Sell
29,500
-408
-1% -$23.7K 0.01% 926
2024
Q4
$1.43M Buy
29,908
+5,745
+24% +$295K 0.01% 1041
2024
Q3
$1.38M Buy
24,163
+1,410
+6% +$80.8K 0.01% 1081
2024
Q2
$1.19M Buy
22,753
+412
+2% +$18.1K 0.01% 1096
2024
Q1
$909K Sell
22,341
-1,110
-5% -$41.6K 0.01% 1198
2023
Q4
$867K Buy
23,451
+1,377
+6% +$51.9K 0.01% 1189
2023
Q3
$843K Buy
22,074
+130
+0.6% +$5.33K 0.01% 1125
2023
Q2
$940K Buy
21,944
+227
+1% +$7.75K 0.01% 1078
2023
Q1
$829K Hold
21,717
0.01% 1089
2022
Q4
$1.22M Sell
21,717
-20,065
-48% -$1.03M 0.06% 315
2022
Q3
$1.65M Buy
41,782
+17
+0% +$751 0.02% 706
2022
Q2
$1.84M Sell
41,765
-7
-0% -$303 0.02% 798
2022
Q1
$1.67M Sell
41,772
-38
-0.1% -$1.35K 0.01% 867
2021
Q4
$1.68M Sell
41,810
-41,424
-50% -$1.55M 0.01% 889
2021
Q3
$3.39M Buy
83,234
+41,534
+100% +$1.74M 0.02% 672
2021
Q2
$1.89M Hold
41,700
0.02% 779
2021
Q1
$1.74M Buy
+41,700
New +$1.9M 0.02% 769
2019
Q4
Sell
-15,570
Closed -$242K 1669
2019
Q3
$242K Sell
15,570
-17
-0.1% -$280 ﹤0.01% 1416
2019
Q2
$268K Buy
15,587
+377
+2% +$6.08K ﹤0.01% 1344
2019
Q1
$245K Sell
15,210
-255
-2% -$4.13K ﹤0.01% 1294
2018
Q4
$226K Buy
+15,465
New +$247K 0.01% 1148

Other funds holding HALO

Private Advisor Group's HALO Position: Q4 2025 in Review

Private Advisor Group sold out of Halozyme (HALO) in Q4 2025, closing a stake of 23,623 shares — an estimated $1.73M sold.

Private Advisor Group first reported a position in HALO in Q4 2018 and held it in 23 quarters. The position peaked at $3.39M in Q3 2021. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Private Advisor Group reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Private Advisor Group sold 23,623 Halozyme shares in Q4 2025, an estimated $1.73M.
  • Private Advisor Group first reported a position in Halozyme in Q4 2018 and held it in 23 quarters.
  • Private Advisor Group's Halozyme position peaked at $3.39M in Q3 2021.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Private Advisor Group's 13F filing for Q4 2025, filed 17 Feb 2026.